Chemical And Biological Defense: Observations on DOD's Plans To Protect U.S. Forces, Statement of Mark E. Gebicke, Director, Military Operations and Capabilities Issues, National Security and International Affairs Division, Testimony Before the Committee on Veterans' Affairs, U.S. Senate   [open pdf - 56KB]

"In examining Department of Defense's (DOD) experience in preparing its forces to defend against potential chemical and biological agent attacks during the Gulf War, we identified numerous problems. Specifically, we found shortages in individual protective equipment, inadequate chemical and biological agent detection devices, inadequate command emphasis on chemical and biological capabilities, and deficiencies in medical personnel training and supplies. While many deficiencies noted during the Gulf War remain unaddressed today, DOD has increasingly acknowledged and accepted the urgency of developing a capability to deal with the chemical and biological threat to its forces. Both the Congress and DOD have acted to provide greater protection for U.S. forces. Their actions have resulted in increased funding, and the fielding of more and better chemical and biological defense equipment. DOD must address remaining critical deficiencies if U.S. forces are to be provided with the resources necessary to better protect themselves. […] DOD is now embarking on a major effort to protect U.S. forces from the threat of the deadly biological agent anthrax. Its program to immunize millions of active and reserve forces against anthrax, ensuring that each receives the prescribed vaccinations in the proper time sequence, will be a challenge."

Report Number:
Public Domain
Retrieved From:
Government Accountability Office: http://gao.gov
Media Type:
Help with citations